Repro Labs

Repro Labs focuses on reproductive medicine services and equipment in India.

About Repro Labs

Repro Labs is a Healthcare company. Repro Labs focuses on reproductive medicine services and equipment in India. Its Indian entity Repro Labs India Private Limited reported revenue of β‚Ή22.62 Cr. Repro Labs offers products and services including Andrology Services and Laboratory Equipment. Its focus areas include Biotechnology, Reproductive Medicine, Assisted Reproductive Technologies and Medical Services.

Company details

Systems, products, and services for the preparation, cultivation, and storage of human cells and tissue in assisted reproductive technologies are developed and offered by Repro Labs. Andrology laboratory services for male infertility treatment are provided to gynaecologists throughout the year. A team of experienced professionals is dedicated to helping couples achieve parenthood by adapting to advancements in reproductive medicine and making these technologies accessible at reasonable costs. Locations include Chennai and other Indian cities, with operations aimed at supporting infertility evaluations and treatments.

Key Metrics
  • Indian entity revenue
    ₹22.62 Cr

    FY 2025 · +10% YoY

  • Indian entity net profit
    ₹31.9 Lakh

    FY 2025 · 1% margin

  • Indian entity EBITDA
    ₹89 Lakh

    FY 2025 · 4% margin

Products & Services of Repro Labs

Repro Labs offers a comprehensive portfolio of products and services, including Andrology Services and Laboratory Equipment.

Andrology Services
Medical Services

Services for the treatment of male infertility are provided through laboratory testing and analysis.

Laboratory Equipment
Medical Devices

Equipment such as incubators and freezers is supplied for the storage and cultivation of human cells and tissue.

Board of directors of Repro Labs India Private Limited (Repro Labs)

Repro Labs India Private Limited is the primary company behind Repro Labs. The board of Repro Labs India Private Limited currently have 2 directors; the longest-serving is Mahadev Suresh, appointed in 2010. 3 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Mahadev Suresh
DIN 03092823
Managing Director28 Jul 201016 yrs 3 moRepro Labs India Private Limited
Dugganahalli Chikkaputtegowda Sindhu Shree
DIN 09608810
Director18 May 20224 yrs 5 moRepro Labs India Private Limited

Financials of Repro Labs

Figures of Repro Labs India Private Limited, the primary company behind Repro Labs, for FY 2025. Revenue was ₹22.62 Cr (+10% year on year). Net profit was ₹31.9 Lakh (1% margin). EBITDA was ₹89 Lakh (4% margin). Revenue has grown at a compounded annual rate of +13% over three years and +14% over five years.

  • ₹22.62 CrRevenue · FY 2025 · +10% YoY
  • ₹31.9 LakhNet profit · 1% margin
  • ₹89 LakhEBITDA · 4% margin
  • ₹5 LakhPaid-up capital
  • 30Employees (provident fund records)
  • +13%Revenue CAGR, 3 years
  • +14%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Repro Labs India Private Limited are on its company page.

Premium access

Detailed financial statements for Repro Labs

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Repro Labs

The primary company behind Repro Labs, Repro Labs India Private Limited, reported revenue of β‚Ή22.62 Cr for FY 2025, up 10% year on year.

Systems, products, and services for the preparation, cultivation, and storage of human cells and tissue in assisted reproductive technologies are developed and offered by Repro Labs. Andrology laboratory services for male infertility treatment are provided to gynaecologists throughout the year. A team of experienced professionals is dedicated to helping couples achieve parenthood by adapting to advancements in reproductive medicine and making these technologies accessible at reasonable costs. Locations include Chennai and other Indian cities, with operations aimed at supporting infertility evaluations and treatments.

Repro Labs offers Andrology Services and Laboratory Equipment.

Repro Labs operates through Repro Labs India Private Limited.

The legal entities of Repro Labs currently have 2 directors, including Mahadev Suresh, Dugganahalli Chikkaputtegowda Sindhu Shree.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available